Company Filing History:
Years Active: 2007-2019
Title: **Bengt Herslöf: Innovator in Pharmaceutical and Cosmetic Carrier Technologies**
Introduction
Bengt Herslöf, a distinguished inventor based in Stockholm, Sweden, has made notable contributions to the field of pharmaceutical and cosmetic technologies. With a portfolio of four patents, his work reflects a deep commitment to innovation in topical administration solutions.
Latest Patents
Herslöf's latest patents focus on a novel sprayable topical carrier and composition comprising phosphatidylcholine. This pharmaceutical or cosmetic carrier is designed for topical administration, primarily consisting of phosphatidylcholine, monoglyceride, and fatty acid esters of C-Calcohol. Additionally, it incorporates a volatile solvent, selected from ethanol and its combinations with C-Calcohol or volatile silicone oil. These patents also detail pharmaceutical and cosmetic compositions that employ this innovative carrier alongside various active agents, enhancing the effectiveness and usability of topical applications.
Career Highlights
Throughout his career, Bengt Herslöf has worked with prominent companies that include Lipidor AB and LTP Lipid Technologies Provider AB. His work at these organizations has not only driven his own research but has also contributed significantly to advancements in lipid-based technologies for drug delivery.
Collaborations
Herslöf has collaborated with esteemed colleagues such as Jan Holmbäck and Per Tingvall, combining their expertise to further develop innovative solutions in the pharmaceutical and cosmetic industries. These partnerships have helped facilitate the exploration of new ideas and formulations.
Conclusion
Bengt Herslöf stands out as a key figure in the realm of innovations related to topical pharmaceutical and cosmetic carriers. His patents reflect a profound understanding of formulation science and a commitment to improving the delivery mechanisms of active agents. As research and development in this area continue to evolve, Herslöf's contributions will undoubtedly play a significant role in shaping the future of topical administration.